HIF1A and neoplasm: In glioblastoma cells, elevated ROS levels can disrupt the protein–protein interactions between HIF-1α and the transcriptional co-activator p300, which prevents the activation of HIF-1α target genes and subsequent tumor growth [66,67,68].